These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16588)

  • 21. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
    Harpel PC
    J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymic properties of the neo-plasmin-Val-422 (miniplasmin).
    Christensen U; Sottrup-Jensen L; Magnusson S; Petersen TE; Clemmensen I
    Biochim Biophys Acta; 1979 Apr; 567(2):472-81. PubMed ID: 36160
    [No Abstract]   [Full Text] [Related]  

  • 23. Molar concentrations of fibrinolytic components, especially free fibrinolysin, in vivo.
    Nanninga LB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):244-55. PubMed ID: 124474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the plasminogen system on rat glomerular epithelial cells.
    Kanalas JJ
    Exp Cell Res; 1995 Jun; 218(2):561-6. PubMed ID: 7796890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid and sensitive proteolytic assay for human plasminogen and plasmin using radioiodinated alpha-casein.
    Highsmith RF; Rosenberg RD
    Thromb Res; 1977 Aug; 11(2):131-40. PubMed ID: 143734
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma.
    Norén I; Ramström G; Wallén P
    Haemostasis; 1975; 4(2):110-24. PubMed ID: 1332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method using fibrin-fixed Blue Dextran for determining the plasmin and plasmin inhibitor activities in human plasma.
    Tamura Y; Otsuka A; Sone K; Sakurai E; Mori H; Sumi H; Kosugi T; Fujii S
    Biochim Biophys Acta; 1978 Jul; 525(1):194-9. PubMed ID: 150858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A; Kramer MD; Schirrmacher V; Brunner G
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic studies of the urokinase-catalysed conversion of NH2-terminal glutamic acid plasminogen to plasmin.
    Christensen U
    Biochim Biophys Acta; 1977 Apr; 481(2):638-47. PubMed ID: 139931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A highly sensitive chromogenic microplate assay for quantification of rat and human plasminogen.
    Kulseth MA; Helgeland L
    Anal Biochem; 1993 May; 210(2):314-7. PubMed ID: 8512067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator.
    Sim PS; Fayle DR; Doe WF; Stephens RW
    Eur J Biochem; 1986 Aug; 158(3):537-42. PubMed ID: 2942403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of plasmin catalyzed conversion of single-chain to two-chain urokinase-type plasminogen activator by sulfated polysaccharides.
    Rydzewski A; Takada Y; Takada A
    Thromb Haemost; 1989 Sep; 62(2):752-5. PubMed ID: 2479114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional assay of plasminogen activator by hydrolysis of 14C-globin.
    Finci Z; Nachshon I; Sharoni Y; Mayer M
    Exp Hematol; 1986 May; 14(4):293-7. PubMed ID: 2938980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.
    Gissler HM; Frank R; Kramer MD
    Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):437-43. PubMed ID: 6457415
    [No Abstract]   [Full Text] [Related]  

  • 39. [Plasminogen (PG) and plasmin (PM)].
    Kondo S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():697-9. PubMed ID: 15658427
    [No Abstract]   [Full Text] [Related]  

  • 40. [Plasminogen (PG), plasmin (PM)].
    Ohta S; Sakuragawa N
    Nihon Rinsho; 1999 Sep; 57 Suppl():667-70. PubMed ID: 10543208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.